Skip to Content

Betamethasone Acetate/Betamethasone Sodium Phosphate Suspension for Injection

Last Updated: November 18, 2019
Status: Resolved

Reason for the Shortage
    • American Regent had betamethasone acetate/betamethasone sodium phosphate on shortage due to minor shipping delays.
    • Merck did not provide a reason for the shortage.
    • Exela Pharma Sciences had betamethasone acetate/betamethasone sodium phosphate on shortage due to increased demand.
Available Products
    • Celestone Soluspan suspension for injection, Merck, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00085-4320-01
    • Betamethasone acetate/betamethasone sodium phosphate suspension for injection, American Regent, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00517-0720-01
    • Betamethasone acetate/betamethasone sodium phosphate suspension for injection, Exela Pharma Sciences, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 51754-5060-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated November 18, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 25, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.